B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KPNB1

MOLECULAR TARGET

karyopherin subunit beta 1

UniProt: Q14974NCBI Gene: 38373 compounds

KPNB1 (karyopherin subunit beta 1) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KPNB1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1molibresib3.8144
2Chlorhexidine0.691
3Reserpine0.691

About KPNB1 as a Drug Target

KPNB1 (karyopherin subunit beta 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented KPNB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KPNB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.